These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11863482)

  • 1. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting.
    Lacy CR; Suh DC; Barone JA; Bueno M; Moylan D; Swartz C; Kudipudi RV; Kostis JB
    Arch Intern Med; 2002 Feb; 162(4):468-73. PubMed ID: 11863482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving lipid evaluation and management in medicare patients hospitalized for acute myocardial infarction.
    Malach M; Quinley J; Imperato PJ; Wallen M
    Arch Intern Med; 2001 Mar; 161(6):839-44. PubMed ID: 11268226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ; Marín Ibáñez A; Pérez-Jiménez F; Pintó X; Nocea G; Ahumada C; Alemao E; Yin D;
    Pharmacoeconomics; 2004; 22 Suppl 3():1-12. PubMed ID: 15669149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
    Pearson TA; Laurora I; Chu H; Kafonek S
    Arch Intern Med; 2000 Feb; 160(4):459-67. PubMed ID: 10695686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.
    LaBresh KA; Owen P; Alteri C; Reilly S; Albright PS; Hordes AR; Shaftel PA; Noonan TE; Stoukides CA; Kaul AF
    Am J Cardiol; 2000 Feb; 85(3A):23A-29A. PubMed ID: 10695704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease.
    Kawecka-Jaszcz K; Jankowski P; Pajak A
    Int J Cardiol; 2003 Sep; 91(1):15-23. PubMed ID: 12957725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of practice setting on quality of lipid-lowering management in patients with coronary artery disease.
    Harnick DJ; Cohen JL; Schechter CB; Fuster V; Smith DA
    Am J Cardiol; 1998 Jun; 81(12):1416-20. PubMed ID: 9645890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not at Goal study (SA-NAG).
    Ramjeeth A; Butkow N; Raal FJ; Maholwana-Mokgatlhe M
    Cardiovasc J Afr; 2008; 19(2):88-94. PubMed ID: 18516354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
    Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
    J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes.
    Mehler PS; Esler A; Estacio RO; MacKenzie TD; Hiatt WR; Schrier RW
    Am J Med; 2003 Apr; 114(5):377-82. PubMed ID: 12714127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of lipid lowering in patients with coronary artery disease by case method learning.
    Kiessling A; Zethraeus N; Henriksson P
    Int J Technol Assess Health Care; 2005; 21(2):180-6. PubMed ID: 15921057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guidelines of lipid therapy translation into clinical practice].
    Rosenberg M; Haass M
    Internist (Berl); 2005 May; 46 Suppl 1():S11-7. PubMed ID: 15864508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.
    Sueta CA; Chowdhury M; Boccuzzi SJ; Smith SC; Alexander CM; Londhe A; Lulla A; Simpson RJ
    Am J Cardiol; 1999 May; 83(9):1303-7. PubMed ID: 10235085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ; Nappi JM; Ragucci KR
    Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.
    Majumdar SR; Gurwitz JH; Soumerai SB
    J Gen Intern Med; 1999 Dec; 14(12):711-7. PubMed ID: 10632815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance and treatment of dyslipidemia in the post-infarct patient: can a nurse-led management approach make a difference?
    Lapointe F; Lepage S; Larrivée L; Maheux P
    Can J Cardiol; 2006 Jul; 22(9):761-7. PubMed ID: 16835670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention of coronary artery disease in contemporary clinical practice.
    Jankowski P; Czarnecka D; Wolfshaut-Wolak R; Łysek R; Łukaszewska A; Bogacki P; Grodecki J; Mirek-Bryniarska E; Nessler J; Podolec P; Kawecka-Jaszcz K; Pająk A
    Cardiol J; 2015; 22(2):219-26. PubMed ID: 25299500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)].
    Föger B; Patsch JR
    Wien Klin Wochenschr; 2011 Jan; 123(1-2):21-7. PubMed ID: 21165704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASCOT-LLA and the primary prevention of coronary artery disease in hypertensive patients.
    Nambi V; Ballantyne CM
    Curr Atheroscler Rep; 2004 Sep; 6(5):353-8. PubMed ID: 15296701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.